Immunity

Multifunctional lipid-based nanocarriers with antibacterial and anti‐inflammatory activities for treating MRSA bacteremia in mice

12 days ago   |   By Journal of Nanobiotechnology

Bacteremia-induced sepsis is a leading cause of mortality in intensive care units. To control a bacterial infection, an immune response is required, but this response might contribute to organ failure. Kidneys...
Read more ...

 

TB study reveals potential targets to treat and control infection

12 days ago   |   By ScienceDaily

Researchers may have found a new pathway to treat and control tuberculosis , the disease caused by Mycobacterium tuberculosis. Using single-cell RNA sequencing , a next-generation sequencing technology, scientists were able to further define the mechanisms that lead to TB infection and latency.
Read more ...

 


Search by Tags

   Immunity      Research      RNA  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Q&A: Johnson & Johnson's vaccine is coming to San Diego. Here's what you...

Dr. Mark Sawyer of Rady Children's Hospital recommended that the FDA authorize Johnson & Johnson's vaccine... Read more ...

San Diego startup DTx Pharma raises $100M for platform to treat rare diseases

Initial RNA treatments are targeting eye diseases and neuromuscular ailments... Read more ...

Protein kinases significantly contribute to the immunodeficiency in HIV patients

A new study indicates that protein kinases, which initiate the process that erodes the body's immunity, significantly contribute to the immunodeficiency in HIV patients. Drugs... Read more ...

FDA accepts gefapixant for review in cough, positioning Merck to get head...

FDA accepts gefapixant for review in cough, positioning Merck to get head start on Bayer and Bellus ntaylor Mon, 03/01/2021 - 08:01 Read more ...

China startup Suzhou Medilink Therapeutics nabs $50M for hot R&D cancer field

China startup Suzhou Medilink Therapeutics nabs $50M for hot R&D cancer field badams Mon, 03/01/2021 - 07:37 Read more ...

SalioGen raises $20M to validate non-viral gene therapy platform

SalioGen raises $20M to validate non-viral gene therapy platform ntaylor Mon, 03/01/2021 - 06:47 Read more ...

Merck KGaA pens $855M upfront, biobucks pact with Debiopharm for next-gen...

Merck KGaA pens $855M upfront, biobucks pact with Debiopharm for next-gen cancer asset badams Mon, 03/01/2021 - 09:17 Read more ...

How 'great' was the great oxygenation event?

Around 2.5 billion years ago, our planet experienced what was possibly the greatest change in its history: According to the geological record, molecular oxygen suddenly went... Read more ...

Abstracts of the 87th Annual Meeting of the German Society for Experimental...

Read more ...

BarCoder: a tool to generate unique, orthogonal genetic tags for qPCR detection

Abstract Background Tracking dispersal of microbial populations in the environment requires specific detection methods that discriminate between the target strain and all... Read more ...